Myriad Genetics to Present at Health Care Conference
MYGN | Quote | Chart | News | PowerRating -- (Comment on this article at http://www.financialwire.net/2009/11/19/myriad-genetics-to-present-at-health-care-conference/)
November 19, 2009 (FinancialWire) -- Myriad Genetics, Inc. (NASDAQ: MYGN | Quote | Chart | News | PowerRating) announced that Peter D. Meldrum, president and CEO, is scheduled to present an overview of the company at the 21st Annual Piper Jaffray Health Care Conference, at 9: 30 a.m. Eastern on December 1, 2009, at the New York Palace Hotel in New York City.
Myriad Genetics, Inc. is a leading healthcare company focused on developing and marketing novel molecular diagnostic products.
FinancialWire(tm) is a fully independent, proprietary news wire service. FinancialWire(tm) is not a press release service, and receives no compensation for its news, opinions or distributions. Further disclosure is at the FinancialWire(tm) web site (http://www.financialwire.net/disclosures.php). Contact FinancialWire(tm) directly via inquiries@financialwire.net.
Free annual reports for companies mentioned in the news are available through the Free Annual Reports Service (http://investrend.ar.wilink.com/?level=279).
http://www.financialwire.net
For full details on Myriad Genetics Inc (MYGN) MYGN. Myriad Genetics Inc (MYGN) has Short Term PowerRatings at TradingMarkets. Details on Myriad Genetics Inc (MYGN) Short Term PowerRatings is available at This Link.
- Downtrend Spotted in Shares of Myriad Genetics (MYGN) - 02/09/10
- Myriad Genetics reports big bump in profits: Net rose 67 percent, revenue up 11 percent in 2nd quarter. - 02/04/10
- Myriad Genetics Inc. (MYGN) Corporate Event Announcement Notice - 02/03/10
- Myriad Genetics Inc. (MYGN) Corporate Event Announcement Notice - 02/02/10
- Myriad Genetics Reports Financial Results for Fiscal 2010 Second Quarter - 02/02/10
- More News >>


